Células natural killer y el sistema inmune innato en la patología infecciosa

por Sepúlveda C,Cecilia, Puente P,Javier
Publicado 2000

Leucemia de células natural killer: Caso clínico

por Guerrero A,Mario, Lira V,Pablo, Bertin C,Pablo, Galleguillos V,Mauricio, Ocqueteau T,Mauricio
Publicado 2005

Neoplasia blástica de células dendríticas plasmocitoides. Casos clínicos

por Avilés-Salas,Alejandro, Candelaria,Myrna, Ponce,Mayra, Cañavera-Constantino,Abraham, Burgos,Sebastián
Publicado 2017

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90

por Tanmoy Saha, Tanmoy Saha, Amanda A. van Vliet, Chunxiao Cui, Jorge Jimenez Macias, Arpita Kulkarni, Arpita Kulkarni, Luu Nhat Pham, Sean Lawler, Jan Spanholtz, Anna-Maria Georgoudaki, Adil Doganay Duru, Aaron Goldman, Aaron Goldman, Aaron Goldman, Aaron Goldman
Publicado 2021

Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumonia

por Alice G. Vassiliou, Edison Jahaj, Maria Pratikaki, Chrysi Keskinidou, Maria Detsika, Eirini Grigoriou, Katherina Psarra, Stylianos E. Orfanos, Alexandra Tsirogianni, Ioanna Dimopoulou, Anastasia Kotanidou
Publicado 2021

Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity

por Charles T. Lutz, Lydia Livas, Steven R. Presnell, Morgan Sexton, Peng Wang
Publicado 2021

NATURAL KILLER CELL EFFECTS UPON ANGIOGENESIS UNDER CONDITIONS OF CONTACT-DEPENDENT AND DISTANT CO-CULTURING WITH ENDOTHELIAL AND TROPHOBLAST CELLS

por K. L. Markova, O. I. Stepanova, A. R. Sheveleva, N. A. Kostin, V. A. Mikhailova, S. A. Selkov, D. I. Sokolov
Publicado 2019

Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules

por Vivian Vasconcelos Costa, Weijian Ye, Qingfeng Chen, Mauro Martins Teixeira, Peter Preiser, Eng Eong Ooi, Jianzhu Chen
Publicado 2017

Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus

por Kaliamurthi S, Selvaraj G, Kaushik AC, Gu KR, Wei DQ
Publicado 2018

Immune enhancement activities of silk lutein extract from Bombyx mori cocoons

por Promphet,Porkaew, Bunarsa,Sirirat, Sutheerawattananonda,Manote, Kunthalert,Duangkamol
Publicado 2014

Microvesicles produced by natural killer cells of the NK-92 cell line affect the phenotype and functions of endothelial cells of the EA.Hy926 cell line

por K. L. Markova, V. A. Mikhailova, A. V. Korenevsky, Yu. P. Milyutina, V. V. Rodygina, E. P. Aleksandrova, A. S. Markov, O. A. Balabas, S. A. Selkov, D. I. Sokolov
Publicado 2020

Editorial: Innate Lymphoid Cells in Cancer: Friends or Foes?

por Nicolas Jacquelot, Emilie Narni-Mancinelli, Alexander D. Barrow
Publicado 2021

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy

por Hamilton G, Plangger A
Publicado 2021

NATURAL KILLER T CELLS IN HEPATIC LEUCOCYTE INFILTRATES IN PATIENTS WITH MALIGNANT PROCESS AND VIRAL HEPATITIS

por O. V. Lebedinskaya, I. N. Kabanovskaja, N. K. Akhmatova, E. A. Lebedinskaya, A. V. Lazareva, M. V. Kiselevsky
Publicado 2014

MALDI-TOF mass spectrometric protein profiling of microvesicles produced by the NK-92 natural killer cell line

por A. V. Korenevsky, A. D. Shcherbitskaia, M. E. Berezkina, K. L. Markova, E. P. Alexandrova, O. A. Balabas, S. A. Selkov, D. I. Sokolov
Publicado 2020

Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery

por Marisa Market, Gayashan Tennakoon, Rebecca C. Auer
Publicado 2021

EZH2 identifies the precursors of human natural killer cells with trained immunity

por Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li, Xiubao Ren
Publicado 2021

EVALUATION OF IMMUNOTOXICITY OF THE THERAPEUTIC DRUG PROLONGED ACTION FOR MULTIPLE SCLEROSIS ON RHESUS MONKEYS

por A. B. Dzheliya, Ya. Yu. Ustyugov, M. A. Kortava
Publicado 2015

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies

por Erica L. Heipertz, Evan R. Zynda, Tor Espen Stav-Noraas, Andrew D. Hungler, Shayne E. Boucher, Navjot Kaur, Mohan C. Vemuri
Publicado 2021

Innate Lymphoid Cells and Natural Killer Cells in Bacterial Infections: Function, Dysregulation, and Therapeutic Targets

por Noha Mousaad Elemam, Noha Mousaad Elemam, Rakhee K. Ramakrishnan, Rakhee K. Ramakrishnan, Jennifer E. Hundt, Rabih Halwani, Rabih Halwani, Rabih Halwani, Azzam A. Maghazachi, Azzam A. Maghazachi, Qutayba Hamid, Qutayba Hamid, Qutayba Hamid
Publicado 2021